Life
Briefing: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial
Strategic angle: Xenon Pharmaceuticals reported significant reduction in seizure frequency with its new treatment compared to placebo.
editorial-staff
1 min read
Updated about 1 month ago
Summary
- Treatment targets a common type of seizure disorder.
- Results from late-stage clinical trials indicate strong efficacy.
- Xenon Pharmaceuticals aims to address unmet medical needs.